Genzyme Corporate Genetics Home Search Contact Us Genzyme Websites
Test Menu Health Care Professionals Patients Managed Care Organizations About Genzyme Genetics
Genzyme Genetics

Quick Links:
 Go

Genzyme Websites

Genzyme Business Sites

  • Genzyme Biosurgery
    Genzyme Biosurgery is a leading developer of novel biotherapeutic and biomaterial products, including Carticel ® and Synvisc ®.
  • Genzyme Diagnostics
    Genzyme Diagnostics offers a unique product portfolio for diagnostic manufacturers and clinical laboratories worldwide, with three key product areas: clinical chemistry, rapid tests and point of care diagnostics.
  • Genzyme Genetics
    Genzyme Genetics is a leading worldwide provider of reproductive and oncology diagnostic testing, as well as genetic counseling services.
  • Genzyme Oncology
    Genzyme Oncology is focused on developing and commercializing novel treatments for cancer patients. It has a full pipeline and two marketed therapeutics: Campath ® and Clolar ®.
  • Genzyme Pharmaceuticals
    Genzyme Pharmaceuticals develops and manufactures specialty pharmaceutical/drug materials and value added technologies, products and services with an immediate focus in the lipid, peptide, amino acid derivatives and drug delivery markets.

Genzyme Joint Venture Site

  • MG Biotherapeutics
    MG Biotherapeutics is a Medtronic-Genzyme joint venture to develop cell therapy solutions for unmet medical needs in cardiovascular disease through the combination of biologics and delivery devices.

Genzyme Product Sites for US Audiences

  • Aldurazyme®
    Aldurazyme (laronidase) is an enzyme replacement therapy for mucopolysaccharidosis I (MPS I).
  • Campath®
    Campath (alemtuzumab for injection) is indicated for the treatment of B-cell chronic lymphocytic leukemia in patients who have been treated with alkylating agents and have failed fludarabine therapy.
  • Carticel®
    Carticel (autologous cultured chondrocytes) employs a unique process to grow a patient’s own cartilage cells for implantation to correct certain types of knee cartilage damage.
  • Cerezyme®
    Cerezyme (imiglucerase for injection) is an enzyme replacement therapy for Type 1 Gaucher disease.
  • Clolar®
    Clolar (clofarabine) is indicated for the treatment of children with refractory or relapsed acute lymphoblastic leukemia (ALL).
  • Epicel®
    Epicel (cultured epidermal autografts) is a permanent skin replacement product that is available for patients with life-threatening burns.
  • Fabrazyme®
    Fabrazyme (agalsidase beta) is an enzyme replacement therapy for Fabry disease.
  • Hectorol®
    Hectorol (doxercalciferol) is indicated for the treatment of secondary hyperparathyroidism in patients with stage 3 or stage 4 chronic kidney disease and patients with stage 5 chronic kidney disease on dialysis.
  • Myozyme®
    Myozyme (alglucosidase alfa) is an enzyme replacement therapy for Pompe disease.
  • Renagel®
    Renagel (sevelamer hydrochloride) is a calcium-free, metal-free phosphate binder that controls serum phosphorus levels in patients with chronic kidney disease on hemodialysis.
  • Renvela®
    Renvela (sevelamer carbonate)is a next-generation version of Renagel® (sevelamer hydrochloride), the most-prescribed phosphate binder in the United States.
  • Seprafilm®
    Seprafilm is a temporary, physical adhesion barrier for abdominal and pelvic adhesion prevention.
  • Synvisc®
    Synvisc for patients
    | Synvisc for health care professionals
    Synvisc (hylan G-F 20) is a local therapy that provides lubrication for the knee joint and can help reduce or stop pain in an osteoarthritic knee.
  • Thymoglobulin®
    Thymoglobulin [Anti-thymocyte Globulin (Rabbit)] is an immunosuppressive polyclonal antibody that is used in conjunction with concomitant immunosuppression to treat acute rejection in kidney transplant patients.
  • Thyrogen®
    Thyrogen (thyrotropin alfa for injection) is an adjunctive diagnostic used in follow-up screenings of cancer patients with well-differentiated thyroid cancer who have had their thyroid glands removed.

Genzyme Product Sites for EU Audiences

Genzyme Disease Education/Research/Support Sites

Genzyme International Subsidiaries Sites

  Contact Information

Genzyme Genetics
Tel: (800) 357-5744
Fax: (508) 389-5577

Terms and Conditions of Use | Privacy Policy | © 2002-2008 Genzyme Corporation. All rights reserved.